Flow -through anti-SA immuno dot blot is developed to Detect S.aureus bacteria by specific Monoclonal antibody against Surface proteins like Microbial Surface Components recognizing Adhesive Matrix Molecules (MSCRAMMs) are major virulence factors of pathogenic gram positive bacteria.
The Problem - Sepsis
Neonatal sepsis is a major cause of morbidity worldwide and one of the three primary causes of 2.7million death every year.over 6,00,000 of these deaths are attributed to infection alone and 99% of these deaths take place in developing country setting. Of the 6.9 million neonatal sepsis burden,south asia accounts for 3.5 million cases per year. India, with its 1.2 billion population, claims a large proportion of this disease burden.These sepsis related neonatal deaths are considered to be taking place in rural india where more than 60% of the Indian population lives.
Time Consuming
Relies on blood cultures, which require 24-48 hours incubation periods before on antibiotics.
Very Expensive
Rural patients cannot afford for Blood culture and other molecular diagnostics
Lab needed
A lab set-up and instruments are expensive, set-up process and managing lab is hassle.
Skilled Staff
Well trained staff is needed to perform the assay and interpret the results.
Transport
Samples need to be transported to the stringent environment with specialized facilities.
Our Solution
Flow -through anti-SA immuno dot blot
The Benefits
Rapid
Test performed in 15 minutes at the patient's side.
Accessible
Easy access to the care diagnostic in remote locations
Sensitive & Specific
Targets specific protein on bacterial surface.
Affordable
1⁄3rd cost savings vs current diagnostic.
How it works
Hassle-free usage of product as easy as in 3 steps
1. Collect Blood Sample
A quick blood draw from patient.
2. Test with Kit
Flow -through anti-SA immuno dot blot
3. Results
Fast diagnosis of sepsis in minutes
